1
2
3
4
5
6
2
3
4
5
6
Published In
Archives of Rheumatology
Volume: 35 Issue: 3, September 2020
Pages: 366-375
History
Published Online: September 30, 2020
This work is licensed under a Creative Commons Attribution 4.0 International License.
Kyung-Ann LEE
Department of Internal Medicine, Soonchunhyang University School of Medicine, Seoul, South Korea
Bo Young KIM
Department of Internal Medicine, Gangneung Asan Hospital, Gangneung, South Korea
Sung Jae CHOI
Department of Internal Medicine, Korea University, Ansan, South Korea
Seong-Kyu KIM
Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, South Korea
Sang-Hyon KIM
Department of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, South Korea
Hyun-Sook KIM
Department of Internal Medicine, Soonchunhyang University School of Medicine, Seoul, South Korea
Kyung-Ann LEE, Bo Young KIM, Sung Jae CHOI, Seong-Kyu KIM, Sang-Hyon KIM, & Hyun-Sook KIM. (2020). A Real-World Experience of Mycophenolate Mofetil for Systemic Sclerosis: A Retrospective Multicenter Observational Study. Archives of Rheumatology, 35(3), 366–375. https://doi.org/10.46497/ArchRheumatol.2020.7771
Abstract
Objectives: This study aims to assess the efficacy and safety of mycophenolate mofetil (MMF) on lung function and skin thickness in Korean patients with systemic sclerosis-interstitial lung disease (SSc-ILD) in a real-world setting.
Patients and methods: This retrospective, medical chart-based study was performed at four centers in South Korea and included 34 patients (2 males, 32 females; median age 50.5 years; range, 25 to 72 years) with SSc-ILD. We investigated changes in forced vital capacity (FVC), diffusion capacity of the lung for carbon monoxide (DLCO), and modified Rodnan skin score (mRSS) according to MMF treatment for 24 months.
Results: The mean dose and treatment duration of MMF were 1,338.2±439.0 mg/day and 13.1±9.3 months, respectively. Although FVC decreased significantly at 15 months, FVC and DLCO did not change significantly during treatment with MMF. Median mRSS decreased significantly from 17.5 (2-40) to 10.5 (2-40) units (p<0.0001). Thirteen patients (38.24%) discontinued treatment with MMF [treatment duration 8.00 (3.0-24.0) months]; the predominant cause of discontinuation was of economic nature (46.15%). No serious adverse events were reported.
Conclusion: This real-world based study supports the role of MMF in the stabilization of lung function and the improvement in skin thickness with an acceptable safety profile in patients with SSc. Economic burden is the main cause of discontinued treatment with MMF.
Similar Articles
Similar Articles
- Çiğdem Seher KASAPKARA, Meltem AKÇABOY, Fehime KARA EROĞLU, Betül Emine DERİNKUYU, Mucolipidosis Type III: A Rare Disease in Differential Diagnosis of Joint Stiffness in Pediatric Rheumatology , Archives of Rheumatology: Vol. 33 No. 1 (2018): The Archives of Rheumatology
- Julia RIERA, Jorge MUSURUANA, Cecilia COSTA, Javier CAVALLASCA, Efficacy of Rituximab for Refractory Pyoderma Gangrenosum-Like Ulcers in Granulomatosis With Polyangiitis Associated to Antiphospholipid Antibodies , Archives of Rheumatology: Vol. 35 No. 3 (2020): The Archives of Rheumatology
- Yazhi Wei, Liping Dai, Yanqun Deng, Zhizhong Ye, LncRNA XIST promotes adjuvant-induced arthritis by increasing the expression of YY1 via miR-34a-5p , Archives of Rheumatology: Vol. 38 No. 1 (2023): The Archives of Rheumatology
- Anna RACZKIEWICZ, Aleksandra JUSZKIEWICZ, Malgorzata TLUSTOCHOWICZ, Witold TLUSTOCHOWICZ, Polish Rheumatologists and Rheumatoid Arthritis Patients Differ in Their Opinions About Treatment Inefficacy , Archives of Rheumatology: Vol. 30 No. 3 (2015): The Archives of Rheumatology
- Hong Ki Min, Se Hee Kim, Hae-rim Kim, Sang-heon Lee, Solitary syndesmophyte in odontoid process of a patient with ankylosing spondylitis , Archives of Rheumatology: Vol. 38 No. 3 (2023): The Archives of Rheumatology
- Ye-Rin Heo, Chang-Nam Son, Won-Ki Baek, Sang-Hyon Kim, Grape seed proanthocyanidin extract induces apoptotic and autophagic cell death in rheumatoid arthritis fibroblast-like synoviocytes , Archives of Rheumatology: Vol. 37 No. 3 (2022): The Archives of Rheumatology
- Joy Artin, Yumn A. Elsabagh, Laila Rashed, Mohamed A. Hussein, Proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis: A marker of disease activity and severe disease manifestations with potential therapeutic implementations , Archives of Rheumatology: Vol. 38 No. 2 (2023): The Archives of Rheumatology
- Aditya DHANAWAT, Partisha GUPTA, Prasanta PADHAN, Mixed Connective Tissue Disease With Retroperitoneal Fibrosis: A Rare Occurrence , Archives of Rheumatology: Vol. 35 No. 1 (2020): The Archives of Rheumatology
- Amra ADROVIC, Sezgin ŞAHİN, Kenan BARUT, Özgür KASAPÇOPUR, Juvenile Scleroderma: A Referral Center Experience , Archives of Rheumatology: Vol. 33 No. 3 (2018): The Archives of Rheumatology
- Nehir Samancı, Cahit Kaçar, Meltem Sayın, Tiraje Tuncer, METABOLIC, ENDOCRIN AND SOCIO -CULTURAL RISK FACTORS IN PATIENTS WITH PRIMARY OSTEOARTHRITIS OF THE KNEE AND RELATIONSHIP WITH RADIOLOGICAL FINDINGS , Archives of Rheumatology: Vol. 18 No. 2 (2003): The Archives of Rheumatology
<< < 5 6 7 8 9 10 11 12 13 14 > >>
You may also start an advanced similarity search for this article.
Article Info
Published In
Journal
Archives of Rheumatology
Volume / Issue
Vol. 35 No. 3 (2020): The Archives of Rheumatology
Pages
366-375
History
Published Online
September 30, 2020
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Affiliations
1
Kyung-Ann LEE
Department of Internal Medicine, Soonchunhyang University School of Medicine, Seoul, South Korea
2
Bo Young KIM
Department of Internal Medicine, Gangneung Asan Hospital, Gangneung, South Korea
3
Sung Jae CHOI
Department of Internal Medicine, Korea University, Ansan, South Korea
4
Seong-Kyu KIM
Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, South Korea
5
Sang-Hyon KIM
Department of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, South Korea
6
Hyun-Sook KIM
Department of Internal Medicine, Soonchunhyang University School of Medicine, Seoul, South Korea
Cite this Article
Kyung-Ann LEE, Bo Young KIM, Sung Jae CHOI, Seong-Kyu KIM, Sang-Hyon KIM, & Hyun-Sook KIM. (2020). A Real-World Experience of Mycophenolate Mofetil for Systemic Sclerosis: A Retrospective Multicenter Observational Study. Archives of Rheumatology, 35(3), 366–375. https://doi.org/10.46497/ArchRheumatol.2020.7771
Outlines